IMDX
Insight Molecular Diagnostics Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Insight Molecular Diagnostics Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Insight Molecular Diagnostics Inc.
2.97
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Broadwood CapitalBroadwood Capital | $74.8M | 68.70% | +6.31% | |
| 2 | AWM InvestmentAWM Investment | $16.7M | 15.36% | +1.08% | |
| 3 | Vanguard Capital ManagementVanguardindex-like | $4.3M | 3.99% | +36.99% | |
| 4 | Pura Vida InvestmentsPura Vida | $2.9M | 2.63% | −48.81% | |
| 5 | Family Office ResearchFamily Office Research | $2.2M | 2.00% | +189.83% | |
| 6 | Geode Capital ManagementGeodeindex-like | $1.5M | 1.39% | −1.97% | |
| 7 | FNY Investment AdvisersFNY Investment | $1.1M | 0.99% | −26.21% | |
| 8 | Jane Street GroupJane Street | $930,324 | 0.85% | new | |
| 9 | BlackRockBlackRockindex-like | $888,074 | 0.82% | +11.21% | |
| 10 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $734,998 | 0.67% | −6.04% | |
| 11 | State StreetState Streetindex-like | $543,532 | 0.50% | +81.51% | |
| 12 | Millennium ManagementMillennium | $486,744 | 0.45% | −20.27% | |
| 13 | UBS GroupUBS | $314,329 | 0.29% | +134.17% | |
| 14 | Northern TrustNorthern Trustindex-like | $289,631 | 0.27% | 0.00% | |
| 15 | Advisor Group HoldingsAdvisor | $230,901 | 0.21% | +62.15% | |
| 16 | Morgan StanleyMorgan Stanley | $209,539 | 0.19% | −1.59% | |
| 17 | Leucadia NationalLeucadia National | $106,790 | 0.10% | new | |
| 18 | Marshall WaceMarshall Wace | $97,922 | 0.09% | new | |
| 19 | ExodusPoint Capital ManagementExodusPoint | $82,771 | 0.08% | new | |
| 20 | AXQ CapitalAXQ Capital | $79,101 | 0.07% | new | |
| 21 | Flatrock Wealth PartnersFlatrock Wealth Partners | $76,960 | 0.07% | 0.00% | |
| 22 | Two Sigma InvestmentsTwo Sigma | $65,496 | 0.06% | new | |
| 23 | XTX TopcoXTX Topco | $63,384 | 0.06% | −64.61% | |
| 24 | Private Advisor GroupPrivate Advisor | $61,454 | 0.06% | 0.00% | |
| 25 | BNP Paribas ArbitrageBNP Paribas Arbitrage | $34,226 | 0.03% | +8964.06% |
40 managers report $108.9M of Insight Molecular Diagnostics on form 13F for the quarter ended Jun 30 '26. 2 of them hold 80% of it; Broadwood Capital is largest at 68.70%.
No implied move.
No implied move.
Expected move
No implied move.